Ligand validation:3QDV

A2G: 2-acetamido-2-deoxy-alpha-D-galactopyranose

A2G is a Ligand Of Interest in 3QDV designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3QDV_A2G_B_144	90%	66%	0.078	0.96	0.76	0.55	-	-	0	0	100%	1
3QDV_A2G_A_144	89%	63%	0.083	0.962	0.7	0.69	-	-	0	0	100%	1
3QDW_A2G_B_144	85%	46%	0.089	0.955	0.8	1.32	-	2	0	0	100%	1
2A2D_A2G_A_459	99%	14%	0.053	0.991	1.08	2.92	1	6	0	0	100%	1
5T5P_A2G_b_201	99%	29%	0.046	0.982	1.11	1.86	2	3	0	0	100%	0.9333
5T5J_A2G_a_201	99%	43%	0.049	0.983	0.94	1.31	-	2	0	0	100%	0.9333
8PN5_A2G_I_101	99%	31%	0.049	0.98	1.82	1.08	3	1	0	0	100%	0.9333
5XG5_A2G_A_201	98%	41%	0.053	0.977	1.35	1.01	3	1	0	0	100%	1

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.